FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
Introduction Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD). The strong association between gut and liver inflammation has driven several pathogenic hypotheses to which the intestinal microbiome is proposed to contribute. Pilot s...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2025-01-01
|
| סדרה: | BMJ Open |
| גישה מקוונת: | https://bmjopen.bmj.com/content/15/1/e095392.full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
